| Today | 5d | 1m | 3m | 1y | 5y | 10y |
| Last: | $0.50 | High: | $0.52 |
| Prev Close: | $0.51 | Low: | $0.50 |
| Open: | $0.51 | Mkt Cap: | $78M |
| Change: | -$0.01 ( -1.96% ) | 52Wk High: | $2.40 |
| Vol: | 1,539,021 | 52Wk Low: | $0.33 |
| Avg Volume: | 2,193,764 | Shares: | 153.89B |
| EPS: | -0.26 | PE Ratio: | - |
A biotechnology company, which develops Surfactant Replacement Therapies for respiratory disorders and diseases.
|
|
Shahid Nisar |
Jul 31 3:40 PM |
|
started an entry limit for its support at .40, for 20k shares, need to load up on this one, tech looks great, 4q of positive earnings pt 2 - |
||
|
|
Paul & Shark |
Jul 04 9:33 AM |
|
This is a warning and example which shows how in a bear market losing money companies get punished instantly. Check your other stocks too. - |
||
|
|
Paul & Shark |
Jul 04 9:31 AM |
|
Dear investors, this is what happens when you buy stocks without looking into balance sheet first, DSCO really has nothing to show there. - |
||
|
|
Cameron Shubert |
Jun 05 11:19 AM |
| currently low - is a promising stock with performance that may be similar to Comment | ||
|
|
Cameron Shubert |
Jun 03 11:09 AM |
|
- major investors r manipulating the stock price to trigger stops and buy back in cheap. its going to...
Comment |
||
|
|
Sanny Djoeva |
May 29 10:45 AM |
|
Synthetic surfactant could b huge.only thing that prevented approval last round was stability/shelf-life, not the actual drug itself - |
||
|
|
Kim Odonnell |
May 18 1:42 PM |
|
surfaxin should finally get approval - DSCO
Comment |
||
Do you have a hot tip on a stock? Share it with our community. Get started by entering the company name or symbol below.
|
||||||||||||||||||||||||||||||